3.77% 0.01

20 20 Biolabs Inc (AIDX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der 20 20 Biolabs Inc-Aktie (AIDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Revenues	106.74% 0.7306	0.3534
Cost Of Revenue	46.59% 0.4258	0.2905
Gross Profit	384.59% 0.3047	0.0629
Operating Expenses	2.84% 1.549	1.5062
Operating Income/Loss	13.80% -1.2442	-1.4434
Nonoperating Income/Loss	64.17% -0.2621	-0.7315
Net Income/Loss	30.74% -1.5063	-2.1748
Preferred Stock Dividends And Other Adjustments	324.50% 0.1217	-0.0542
Basic Average Shares	40.92% 10.79	7.6572
Diluted Average Shares	40.92% 10.79	7.6572
Basic Earnings Per Share	7.14% -0.26	-0.28
Diluted Earnings Per Share	7.14% -0.26	-0.28

AEMD

$5.2225

1.65%

ADGM

$0.1108

8.28%

VVOS

$0.1341

4.62%

POAS

$2.4201

7.98%

CODX

$0.6351

1.88%

NXL

$2.15

0.47%